GW823093 Japan Phase IIa Mono
Phase of Trial: Phase II
Latest Information Update: 06 Sep 2018
At a glance
- Drugs Denagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 31 Aug 2018 Biomarkers information updated
- 20 Oct 2009 Planned end date (1 Oct 2007) added as reported by ClinicalTrials.gov.
- 15 Oct 2008 Actual start date changed from Apr 2006 to May 2006 as reported by ClinicalTrials.gov.